Condition 1: Succinylcholine Chloride. Condition 2: cisatracurium. Poisoning by skeletal muscle relaxants [neuromuscular blocking agents], assault Poisoning by skeletal muscle relaxants [neuromuscular blocking agents], assault
Conditions
Interventions
Intervention 1: Intervention group: After obtaining a license from the Medical Ethics Committee of Isfahan University of Medical Sciences, patients who are willing to participate in the study. In the
Sponsors
Esfahan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
11 Years to 18 Years
Inclusion criteria
Inclusion criteria: People under the age of 18 American Society of Anesthesiology physical status class 1,2
Exclusion criteria
Exclusion criteria: Obesity (index is equal to or greater than 30 History of asthma Allergy Myocardial infarction in the last 6 months Stroke in the last 6 weeks Fibrillation and cardiac flutter Repeated ectopic treatment at the same session Having diseases like high blood pressure and hyperactivity
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Serum potassium levels. Timepoint: Before the administration of the anesthetic (baseline), before induction of the Electroshock (after administration of the drug), after the seizure, and 20 minutes after induction of anesthesia. Method of measurement: potassium test. | — |
Secondary
| Measure | Time frame |
|---|---|
| Heart rate changes. Timepoint: Before the administration of the anesthetic (baseline), before induction of the electroshock (after administration of the drug), after the seizure, and 20 minutes after induction of anesthesia. Method of measurement: Heart monitoring.;Systolic blood pressure. Timepoint: Before the administration of the anesthetic (baseline), before induction of the electroshock (after administration of the drug), after the seizure, and 20 minutes after induction of anesthesia. Method of measurement: Non invasive blood pressure monitor.;Diastolic blood pressure. Timepoint: Before the administration of the anesthetic (baseline), before induction of the electroshock (after administration of the drug), after the seizure, and 20 minutes after induction of anesthesia. Method of measurement: Non invasive blood pressure monitor.;Mean arterial pressure. Timepoint: Before the administration of the anesthetic (baseline), before induction of the electroshock (after administration of the drug), after the seizure, and 20 minutes after induction of anesthesia. Method of measurement: Non invasive blood pressure monitor.;Oxygen saturation. Timepoint: Before the administration of the anesthetic (baseline), before induction of the electroshock (after administration of the drug), after the seizure, and 20 minutes after induction of anesthesia. Method of measurement: Percent with pulse oximeter.;Recovery time. Timepoint: From the end of seizure to full consciousness. Method of measurement: In minutes using a stopwatch. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAtefeh Ghosouri
Esfahan University of Medical Sciences
Outcome results
None listed